virus
human
fatigu
dark
urin
pale
stool
abdomin
pain
loss
appetit
weight
loss
africa
asia
lemoin
et
al
hiv
util
bwa
previou
bioterror
incid
lead
advers
consequ
well
document
variou
review
articl
jansen
et
al
madad
krishan
et
al
follow
histor
pattern
biolog
terror
attack
diseas
outbreak
conclud
biotechnolog
accid
unleash
new
threat
mankind
form
virul
bioweapon
inflict
mass
causal
devast
lesser
et
al
highli
effici
costeffect
medic
countermeasur
base
ethnic
specif
biolog
agent
need
develop
purpos
bioprepared
biosecur
horn
jansen
et
al
pal
et
al
associ
risk
human
pathogen
must
evalu
basi
rate
mortal
avail
treatment
prophylact
measur
need
hospit
public
percept
epidemiolog
spread
rotz
et
al
document
relat
histori
biolog
warfar
difficult
extract
literatur
sinc
alleg
base
sole
eyewit
account
circumstanti
evid
event
moreov
alleg
case
deni
accus
parti
ad
battl
tortona
itali
barbarossa
broaden
scope
biolog
warfar
use
dead
bodi
soldier
well
anim
pollut
well
war
french
centuri
british
forc
direct
sir
jettray
ahmest
gave
blanket
use
smallpox
yellow
fever
victim
nativ
american
order
spread
diseas
frischknecht
us
civil
war
ad
gener
johnson
use
dead
bodi
sheep
pig
pollut
drink
water
videsburg
mississippi
world
war
first
alleg
made
german
attempt
employ
biolog
agent
cholera
itali
plagu
britain
later
accus
use
anthrax
bucharest
romania
metcalf
first
incid
biolog
warfar
document
world
war
million
death
record
due
pandem
outbreak
spanish
influenza
viru
trigger
natur
strike
exampl
indirect
offens
diseas
caus
biolog
agent
use
deterior
combat
capabl
enemi
forc
war
front
perhap
led
establish
concept
biowarfar
agent
bioterror
period
consid
golden
age
biolog
warfar
research
develop
last
decad
sever
incid
bioterrorismbiolog
warfar
record
ainscough
histori
biolog
warfar
program
unit
state
former
soviet
union
fsu
extens
document
literatur
rapidli
evolv
super
power
fsu
initi
biolog
warfar
program
start
show
interest
genet
genet
manipul
potenti
human
pathogen
despit
signatori
member
biolog
toxin
weapon
convent
btwc
fsu
develop
highli
potent
deadli
chimer
biolog
warfar
agent
extens
research
carri
weapon
develop
agent
powder
aerosol
formul
direct
load
munit
spray
tank
cluster
bomb
first
genet
engin
vaccin
toler
pathogen
francisella
tularensi
caus
tularemia
establish
enzym
program
modern
concept
biolog
warfar
repositori
highli
contagi
strain
could
overcom
barrier
immun
system
current
medic
treatment
anthrax
strain
pasechnik
superplagu
strain
glander
strain
myelin
toxin
form
yersinia
pesti
tularemia
schu
virus
like
ebola
marburg
influenza
name
also
tri
hand
product
chimer
virus
introduc
genet
element
venezuelan
equin
enceph
veev
ebola
ebov
marburg
marv
nativ
smallpox
viru
ainscough
russian
scientist
publish
research
paper
journal
vaccin
suggest
method
introduc
bacillu
cereu
gene
b
anthraci
make
resist
russian
anthrax
vaccin
introduct
antibiot
resist
gene
pathogen
strain
significantli
enhanc
lethal
diseas
reduc
treatment
option
athamna
et
al
similarli
prophylact
effect
circumv
suppress
immun
system
express
immun
modifi
gene
use
viral
vector
eg
express
mous
recombin
ectromelia
viru
suppress
immun
function
host
overcom
genet
resist
mous
pox
dna
sequenc
base
investig
preserv
sampl
victim
reveal
simultan
occurr
distinct
virul
variant
b
anthraci
show
continu
biolog
warfar
program
reportedli
deni
time
time
fsu
surprisingli
genet
manipul
procedur
adopt
enhanc
resist
exist
etiolog
agent
high
temperatur
avail
rang
therapeut
antibiot
prophylact
measur
make
novel
immunesuppress
agent
could
easili
weapon
need
fact
indic
violat
btwc
fsu
continu
engag
develop
design
lethal
agent
might
integr
special
war
plan
ainscough
russian
biowarfar
program
came
light
octob
top
rank
microbiologist
director
institut
ultra
pure
biolog
prepar
biopreparat
dr
vladimir
pasechnik
defect
uk
later
lower
level
bench
scientist
pasechnik
lab
refer
code
name
templ
fortun
also
defect
unit
kingdom
year
defect
dr
pasechnik
replic
previou
account
biowarfar
program
disclos
british
govern
late
dr
kanatjan
alibekov
known
ken
alibek
becam
third
defector
russian
biowarfar
program
mangold
goldberg
tucker
ainscough
alibek
articl
biohazard
narrat
firsthand
experi
member
fsu
program
emphas
extens
research
develop
genet
manipul
biolog
warfar
agent
larg
scale
product
facil
weapon
bw
agent
defens
measur
futur
bw
goal
russian
govern
alibek
former
ussr
presid
mikhail
gorbachev
later
russian
presid
bori
yeltsen
announc
termin
biowarfar
program
earli
mani
intellig
analyst
suspect
execut
biowarfar
program
secret
mode
substitut
russian
militari
doctrin
earlier
offic
secretari
defenc
unit
state
also
releas
special
report
prolifer
threat
respons
indic
circul
trend
biolog
warfar
capabl
cohen
also
thriller
novel
written
richard
preston
titl
cobra
event
describ
fiction
bioterror
attack
unit
state
genet
engin
viru
design
cobra
use
spread
design
diseas
call
brain
pox
symptomat
resembl
smallpox
leschnyhan
syndrom
common
cold
otool
soon
septemb
terror
attack
world
trade
centr
pentagon
anthraxlac
letter
sent
nation
legisl
unit
state
result
spread
terror
among
civilian
trigger
adopt
prophylact
measur
commun
mass
scale
two
event
suffici
sensit
presid
bill
clinton
extract
defici
us
nation
secur
result
establish
homeland
secur
council
coordin
effort
exist
nation
agenc
organ
overcom
futur
secur
challeng
ainscough
aken
hammond
provid
three
major
evid
indic
violat
btwc
treati
us
govt
record
one
scientif
write
genet
engin
biolog
weapon
publish
journal
embo
report
us
militari
repeatedli
discuss
possibl
use
biotechnolog
upgrad
offens
warfar
potenti
develop
materi
degrad
microb
destroy
biofuel
construct
materi
stealth
paint
first
evid
emerg
j
campbel
naval
research
laboratori
washington
dc
describ
possibl
applic
genet
modifi
fungi
destroy
militari
paint
h
second
evid
came
light
unit
state
start
conduct
field
trial
pathogen
pleospora
papaveracea
strain
drug
produc
crop
opium
poppi
potenti
risk
success
test
evalu
crop
destruct
tashkant
uzbekistan
similarli
pathogen
fusarium
oxysporum
strain
develop
unit
state
destroy
coca
plant
field
test
schedul
held
columbia
howev
worldwid
protest
field
trial
pathogen
destruct
drug
produc
cocain
benzoylecgonin
ecgonin
cash
crop
produc
strong
public
opposit
lead
termin
project
third
evid
came
use
psychoact
substanc
sleep
gasbz
biolog
weapon
moscow
hostag
crisi
caus
death
peopl
us
marin
corp
also
investig
militari
use
benzodiazepin
adrenoreceptor
agonist
potenti
weapon
btwc
signatur
state
develop
potenti
biowarfar
agent
extens
research
develop
far
deliveri
concern
still
infanc
compar
weapon
biowarfar
agent
fsu
van
aken
hammond
advanc
genet
engin
synthet
biolog
techniqu
complex
genet
manipul
becom
possibl
creation
tailormad
microorgan
harmless
bacteria
virus
made
pathogen
infecti
genet
manipul
mediat
via
multipl
gene
transfer
construct
synthet
chimer
microorgan
moreov
genet
engin
biolog
agent
abil
resist
exist
treatment
therapi
may
potenti
use
biowarfar
agent
biolog
agent
novelalt
pathogen
characterist
enhanc
surviv
infect
virul
drug
resist
refer
next
gener
bioweapon
decod
human
genom
recent
breakthrough
genet
engin
gene
therapi
drug
deliveri
approach
eventu
enhanc
chanc
use
potenti
pathogen
microorgan
next
gener
bioweapon
ainscough
jason
advisori
group
use
provid
technic
advic
us
dept
defenc
brief
near
term
futur
threat
due
develop
genet
engin
bioweapon
ainscough
steven
block
member
jason
group
rais
sever
concern
potenti
bioterrorist
activ
countri
use
next
gener
bioweapon
block
classifi
biowarfar
agent
six
major
group
describ
russian
scientist
master
binari
biolog
weapon
techniqu
use
enhanc
virul
sever
human
pathogen
caus
anthrax
dysenteri
plagu
includ
dual
compon
system
consist
pathogen
host
strain
virul
gene
bear
plasmid
could
individu
propag
larg
scale
deploy
bioweapon
compon
would
mix
togeth
subsequ
biotransform
would
taken
place
within
munit
act
bioreactor
decod
avail
whole
genom
sequenc
data
provid
ampl
opportun
biotechnologist
design
reconstruct
virul
gene
introduc
desir
virul
characterist
exist
repertoir
pathogen
microorgan
advanc
synthet
biolog
techniqu
genet
engin
techniqu
led
feasibl
construct
design
gene
use
creation
genet
modifi
human
pathogen
recent
breakthrough
molecular
cellular
biolog
equip
biologist
develop
design
diseas
creat
design
pathogen
etiolog
agent
achiev
desir
symptom
progress
hypothet
diseas
potenti
target
includ
somat
germ
cell
bodi
tissu
destruct
induc
apoptosi
enhanc
cell
prolifer
caus
cancer
effect
import
tissu
organ
system
immunosuppress
effect
difficult
revers
eg
brain
pox
diseaseth
fiction
diseas
describ
novel
cobra
event
written
r
preston
gene
therapi
base
treatment
chang
genet
composit
patient
program
repair
replac
faulti
gene
huge
potenti
treat
diseas
caus
high
mortal
human
popul
accomplish
germ
cell
somat
cell
bodi
base
upon
sever
diseas
prevent
inherit
futur
gener
success
test
anim
model
eg
vaccinia
viru
use
vector
insert
gene
mammalian
cell
technolog
still
infanc
total
uneth
enrol
human
volunt
introduc
predict
genet
effect
gene
therapi
retrovirus
util
deliveri
vehicl
easili
integr
human
genom
overcom
barrier
natur
defens
system
human
bodi
case
zoonot
diseas
pathogen
viru
natur
anim
reservoir
resid
multipli
littl
effect
observ
carrier
speci
eg
chimpanze
hiv
fruit
bat
monkey
ebola
marburg
pig
swine
flu
etc
readili
transmit
human
carrier
anim
speci
close
contact
human
popul
anim
virus
may
genet
modifi
util
preferenti
human
codon
therebi
elimin
chanc
codon
bias
gener
human
viral
agent
would
seriou
implic
futur
biowarfar
program
consist
cryptic
viral
agent
bear
potenti
human
oncogen
illicitli
secretli
transfer
human
genom
usual
remain
dormant
mani
year
exposur
singl
natur
stimulu
activ
oncogen
determin
present
stealth
virus
could
caus
vast
destruct
human
popul
exampl
human
herp
viru
caus
oral
genit
lesion
induct
similarli
peopl
contract
chicken
pox
previous
present
natur
reservoir
varicella
viru
sometim
rejuven
form
herp
zoster
viru
caus
shingl
diseas
peopl
synthet
biolog
combin
scienc
engin
approach
design
construct
novel
pathway
devic
live
system
well
redesign
natur
biolog
process
exponenti
increas
whole
genom
sequenc
data
last
three
decad
provid
synthet
biologist
virtual
platform
design
reconstruct
virul
effector
element
introduc
necessari
chang
exist
repertoir
pathogen
genet
manipul
refer
templat
assist
assembl
synthet
whole
genom
sequenc
recent
advanc
field
possibl
artifici
synthes
gene
construct
requisit
amount
pathogen
loci
stitch
togeth
creat
infecti
dwarf
genom
even
whole
genom
resembl
natur
human
pathogen
surprisingli
artifici
bacteria
virus
construct
use
natur
genet
segment
isol
extrem
environ
dead
anim
fecal
sampl
preserv
tissu
viral
victim
buri
permafrost
tabl
follow
paragraph
emphas
import
histor
develop
field
synthet
biolog
lead
develop
synthet
nativ
chimer
design
bacteri
viral
agent
first
artifici
bacteriophag
construct
understand
structur
function
viral
genom
infect
import
bacteri
strain
human
relev
smith
cowork
describ
synthesi
bp
genom
stitch
togeth
synthet
dna
fragment
use
polymeras
cycl
assembl
techniqu
research
institut
biolog
energi
altern
ibea
rockvil
maryland
want
use
technolog
construct
artifici
bacteri
chromosom
consist
million
base
pair
dna
artifici
bacteri
chromosom
import
gene
may
use
gener
synthet
microbi
factori
produc
biofuel
hydrogen
cut
carbon
emiss
coal
degasif
unit
chan
colleagu
use
refactor
method
redesign
bacteriophag
genom
bp
aim
studi
import
gene
function
chan
et
al
gener
three
chimer
bacteriophag
name
remov
overlap
genet
segment
replac
bp
stretch
wild
type
wt
genom
bp
synthet
use
recombin
support
e
coli
overlap
segment
conserv
need
viral
replic
removedreplac
maintain
viabil
studi
reveal
potenti
dwarf
genom
perform
replic
function
activ
pave
way
develop
first
synthet
bacteri
clone
describ
whole
genom
synthesi
hervk
con
site
direct
mutagenesi
assist
chemic
synthes
consensu
sequenc
hervk
name
phoenix
hek
cell
line
hek
hela
wop
cell
line
lee
bieniasz
use
systemat
mutagenesi
approach
research
institut
genom
research
tigr
rockvil
maryland
identifi
gene
urethr
caus
mycoplasma
genitalium
essenti
maintain
cell
viabil
support
cell
replic
first
attempt
construct
synthet
bacteri
clone
use
artifici
assembl
genet
construct
initi
result
studi
publish
scienc
indic
minim
genom
content
requir
dna
replic
repair
gene
express
cellular
transport
metabol
energi
gener
live
prokaryot
cell
studi
led
success
synthesi
first
dwarf
bp
genom
genitalium
gibson
et
al
preliminari
investig
genom
transplant
laboratorium
capricolum
reveal
possibl
develop
synthet
speci
use
artifici
construct
bacteri
genom
slow
grow
genitalium
replac
prolif
strain
mycoid
synthes
first
synthet
bacteri
cell
name
mycoid
success
boot
life
gibson
et
al
sleator
glass
work
still
progress
construct
entir
new
design
strain
call
genitalium
contain
minimum
set
essenti
gene
requir
life
studi
potenti
synthet
agent
bioremedi
biomedicin
schemat
represent
show
construct
synthet
virus
synthet
virolog
import
branch
synthet
biolog
undoubtedli
address
mani
diseas
inherit
ancestor
epidemiolog
pathogen
next
gener
agent
possibl
emerg
threat
context
biowarfar
tabl
fig
synthesi
chimer
viral
genom
design
element
construct
artifici
virus
vitro
phage
assembl
develop
deliveri
system
confer
effici
transmiss
design
agent
among
human
favor
trend
field
synthet
virolog
day
histor
influenza
pandem
caus
death
million
person
worldwid
remain
undiscov
taubenberg
cowork
initi
effort
recov
viral
rna
segment
lung
tissu
autopsi
sampl
year
soldier
frozen
tissu
inuit
women
buri
permafrost
among
pandem
victim
taubenberg
et
al
reconstruct
genom
spanish
flu
viru
eight
viral
rna
segment
use
techniqu
gene
sequenc
rtpcr
later
author
success
assembl
artifici
viru
respons
spanish
flu
pandem
techniqu
revers
genet
allow
construct
first
synthet
viru
octob
arm
forc
institut
patholog
rockvil
span
year
neumann
et
al
fodor
et
al
hoffmann
et
al
taubenberg
et
al
taubenberg
et
al
total
eight
gene
hemeagglutinin
ha
neuraminidas
na
polymeras
consid
import
virul
factor
contribut
sever
diseas
sixteen
differ
variant
report
ha
antigen
mainli
aglycoprotein
natur
help
attach
viru
host
cell
nine
subtyp
na
antigen
glycoprotein
report
human
anim
link
epidem
man
other
specif
duck
chicken
ha
na
import
compon
viral
capsid
requir
assembl
infecti
viral
particl
neuraminidas
activ
import
releas
replic
virus
infect
host
cell
spanish
flu
viru
probabl
origin
bird
evolv
caus
epidem
cello
cowork
artifici
construct
polioviru
use
cdna
driven
synthesi
viral
rna
genom
absenc
natur
templat
use
mixtur
biolog
result
rna
genom
subsequ
envelop
gener
artifici
polioviru
cello
et
al
synthet
virolog
approach
follow
investig
function
featur
viral
genom
underli
mechan
pathogen
associ
import
virul
factor
twentyf
mutat
introduc
intent
synthet
cdna
construct
serv
genet
marker
assess
properti
viral
genom
architectur
associ
function
genet
loci
subsequ
artifici
virus
test
infect
use
hela
cell
line
mice
model
confirm
infecti
howev
rate
infect
consider
lesser
wild
type
strain
chemic
synthesi
first
lytic
anim
rna
viru
confirm
accuraci
deduc
viral
genom
sequenc
assign
oncolog
featur
defin
loci
viral
genom
human
endogen
retroviru
includ
class
degener
human
retrovirus
includ
human
mous
mammari
tumor
viruslik
proviru
human
endogen
retroviru
k
proviru
hervk
synthet
consensu
sequenc
sitedirect
mutagenesi
use
gener
infecti
provir
particl
hervk
call
phoenix
dewannieux
et
al
anoth
provir
clone
hervk
con
close
rel
progenetor
hervk
variant
infest
human
genom
million
year
ago
inherit
sinc
human
genom
mendelian
fashion
gener
use
whole
genom
synthesi
lee
bieniasz
thorough
investig
carri
human
cell
line
name
hela
babi
hamster
kidney
felin
murin
wop
cell
line
infect
report
case
hela
wop
cell
line
phoenix
ancestor
provir
strain
may
much
less
infecti
studi
may
provid
valuabl
inform
relat
ancient
provir
genom
repertoir
contribut
immens
human
evolut
physiolog
virus
caus
zoonot
infect
human
immunodefici
viru
simian
immunodefici
viru
sivcpz
natur
reservoir
wild
chimpanze
pan
troglodyt
troglodyt
research
group
isol
viral
nucleic
acid
string
fecal
sampl
wild
pan
troglodyt
troglodyt
deriv
consensu
viral
sequenc
synthes
artifici
use
produc
infecti
molecular
clone
sivcpz
keel
et
al
takehisa
et
al
synthesi
vitro
particl
might
facilit
investig
import
viral
element
determin
cross
speci
transmiss
retrovir
element
mechan
host
adapt
respons
viral
infect
suspect
sarscov
may
reemerg
might
even
deadli
previou
form
due
possibl
cross
speci
transmiss
virul
charact
exist
repertoir
coronaviru
infect
mammal
like
civet
li
et
al
becker
et
al
author
also
fear
replic
acquir
knowledg
relat
virul
genet
loci
assembl
design
pathogen
possibl
might
util
bioweapon
construct
deadli
virus
design
pathogen
confer
effici
transmiss
among
human
rapid
advanc
field
dna
synthesi
sequenc
head
toward
deliber
largescal
genet
manipul
organ
may
extend
wholegenom
synthesi
virus
main
aim
new
approach
understand
organ
pathogen
properti
relat
human
protect
treat
human
viral
diseas
howev
necessari
understand
detail
mechan
packag
viral
genom
enhanc
infect
synthes
host
specif
chimer
construct
differ
model
propos
encapsul
viral
genom
discuss
genom
packag
virus
must
make
distinct
viral
host
nucleic
acid
assist
outer
membran
capsid
protein
receptor
bind
domain
rbd
help
recognit
subsequ
bind
target
genom
case
la
viru
yeast
stemloop
secondari
structur
sitespecif
sequenc
genom
recogn
polymerasegroup
antigen
polgag
fusion
protein
prior
packag
fujimura
et
al
although
applic
viru
synthesi
describ
yet
key
recent
find
resurg
influenza
viru
poliovirus
wimmer
et
al
variou
method
vitro
packag
viral
gene
assembl
infecti
virus
describ
subsequ
paragraph
virus
contain
dsrna
genom
ssrna
act
substrat
packag
motor
protein
ie
atpas
insid
capsid
positivesens
strand
viru
genom
packag
replic
form
dsrna
atpas
compris
hexamer
multifunct
unit
line
helix
loop
play
import
role
procapsid
assembl
ssrna
packag
infect
act
passiv
channel
extrus
newli
synthes
mrna
molecul
viru
genom
enclos
three
segment
dsrna
compris
posit
strand
sequenti
recogn
procapsid
undergo
conform
chang
accommod
rna
segment
loop
vital
rna
bind
transloc
phosphatebind
ploop
upon
atp
hydrolysi
chang
confirm
form
accompani
similar
transit
loop
posit
signifi
drive
forc
rna
transloc
arginin
finger
hexamer
atpas
motor
play
import
role
sequenti
atp
hydrolysi
induc
conform
chang
direct
tran
arginin
finger
activ
center
atpas
neighbor
subunit
thu
trigger
success
atp
hydrolysi
bacteriophag
contain
crystallin
dsdna
genom
end
packag
process
packag
motor
requir
gener
enough
forc
offset
pressur
insid
viral
capsid
influenti
packag
motor
bacteriophag
genom
packag
motor
help
packag
dna
gener
forc
electrostat
interact
base
mechan
propos
viral
genom
packag
bacteriophag
packag
motor
protein
two
domain
ie
ntermin
atpas
domain
ctermin
nucleas
domain
link
togeth
small
amino
acid
provid
flexibl
motor
ensur
packag
atp
hydrolysi
trigger
upon
dsdna
bind
ctermin
domain
subunit
therebi
posit
ci
arginin
finger
ntermin
domain
atpas
activ
center
result
subsequ
conform
chang
chang
align
opposit
charg
nand
ctermin
domain
pull
ctermin
domain
toward
ntermin
domain
action
electrostat
forc
lead
packag
two
base
pair
dsdna
sun
et
al
main
compon
dna
packag
machin
portal
protein
dodecamer
central
channel
line
neg
charg
easi
passag
dna
also
compris
wider
end
insid
capsid
narrow
end
protrud
capsid
energi
atp
hydrolysi
use
rotat
portal
order
drive
dna
procapsid
hugel
et
al
adenoassoci
viru
aav
nonenvelop
icosahedr
parvovirus
contain
ssdna
intact
invert
termin
repeat
itr
result
format
import
secondari
structur
viral
genom
coinfect
helper
viru
like
adenoviru
herp
simplex
viru
hsv
assist
replic
host
cell
polymeras
ni
et
al
vitro
cours
action
packag
aav
studi
zhou
muzyczka
synthesi
infecti
aav
particl
done
use
replicativeform
dna
substrat
aav
rep
capsid
protein
order
transfer
recombin
gene
mammalian
cell
two
type
product
form
heatresist
indic
appropri
ratio
proteintodna
addit
product
also
share
structur
resembl
matur
aav
particl
effici
synthes
particl
enclos
intact
termin
repeat
alway
show
chloroform
dnase
heatresist
pertain
authent
aav
particl
resist
known
vital
properti
packag
purpos
howev
nonpathogen
persist
natur
combin
broad
rang
infect
report
wright
cowork
mark
viru
imper
nomine
therapeut
gene
transfer
vector
wright
et
al
vitro
studi
conduct
cashion
et
al
investig
applic
gene
therapi
treatment
neurolog
diseas
use
human
polyoma
viru
jcv
deriv
viruslik
particl
vlp
vlp
act
deliveri
vector
central
nervou
system
cn
jcv
preferenti
infect
oligodendrocyt
astrocyt
construct
jcvderiv
recombin
insect
cell
respect
packag
strategi
purifi
plasmid
dna
optim
order
illustr
tropism
speci
specif
contain
plasmid
dna
express
egfp
vitro
transduct
done
human
rodent
brainderiv
nonbrain
deriv
cell
signific
transduct
observ
human
prostat
cell
line
thu
assign
effici
select
deliveri
system
therapeut
gene
target
specif
cell
brain
cashion
et
al
techniqu
synthet
biolog
foster
current
challeng
agricultur
industri
biolog
defens
environment
medic
scienc
provid
import
breakthrough
improv
global
scenario
human
anim
health
howev
difficult
rule
possibl
replic
exist
knowledg
domain
synthet
biolog
unlaw
activ
spread
econom
physiolog
distress
global
scale
among
vulner
human
popul
biowarfar
agent
threat
foremost
nation
world
secur
concern
attribut
potenti
econom
psycholog
social
impact
effect
protect
bwa
quit
difficult
intric
detect
expens
protect
measur
counter
threat
sever
countri
establish
biodef
program
strengthen
strategi
detect
protect
decontamin
biowarfar
agent
pal
et
al
earli
detect
identif
bwa
essenti
initi
correct
emerg
respons
manag
incid
effort
made
across
globe
develop
effici
technolog
system
detect
identif
bwa
mani
advanc
molecular
microbiolog
sens
techniqu
antibodybas
immunoassay
cellular
fatti
acid
profil
flow
cytometri
nucleic
acid
base
detect
mass
spectrometri
microbiolog
cultur
genom
analysi
use
primari
identif
biolog
agent
techniqu
highli
reliabl
sensit
select
success
appli
detect
potenti
biowarfar
agent
howev
despit
handi
avail
techniqu
tool
foolproof
system
avail
complet
detect
hazard
biowarfar
agent
regardless
highli
effici
detect
method
possess
variou
drawback
complic
labori
isol
purif
procedur
low
detect
limit
contrast
etiolog
patholog
differ
physiochem
structur
attribut
bioagent
ultim
affect
detect
efficaci
suter
sapsford
et
al
da
kataria
madad
microbiolog
cultur
convent
method
use
isol
identif
biolog
agent
bacteria
fungi
virus
microb
abil
propag
select
cultur
media
allow
target
microorgan
grow
select
cultur
offer
addit
benefit
long
term
viabil
enrich
concern
microb
character
variou
test
employ
morpholog
identif
biochem
character
particular
biolog
agent
microbiolog
cultur
highli
reliabl
specif
labori
time
consum
limit
efficaci
pal
et
al
flow
cytometri
involv
scatter
laser
light
emiss
fluoresc
excit
dye
link
bacteri
cell
cell
size
cell
count
case
liquid
suspens
estim
laser
light
scatter
monoclon
antibodi
fluoresc
label
also
use
detect
variou
pathogen
biowarfar
agent
b
anthraci
b
melitensi
botulinum
toxin
f
tularensi
pesti
easili
identifi
use
flow
cytometri
techniqu
mcbride
et
al
hindson
et
al
two
separ
report
abel
cowork
kaneda
describ
bacteri
identif
method
base
cellular
fatti
acid
profil
bacteri
strain
easili
distinguish
term
variabl
fatti
acid
structur
profil
firstli
convers
cellular
fatti
acid
fatti
acid
methyl
ester
take
place
follow
analysi
ga
liquid
chromatographi
gc
chromatogram
gener
import
fatti
acid
fingerprint
success
employ
identif
character
variou
biolog
agent
viz
b
anthraci
b
mallei
brucella
b
pseudomallei
f
tularensi
pesti
abel
peterson
kaneda
pal
et
al
molecular
biolog
techniqu
offer
specif
rapid
identif
biowarfar
agent
compar
convent
microbiolog
techniqu
polymeras
chain
reaction
pcr
base
assay
identifi
organ
basi
presenc
specif
dna
sequenc
organ
quantit
realtim
pcr
qpcr
base
specif
nonspecif
detect
also
use
amplif
simultan
detect
target
pcrbase
identif
report
case
variou
biowarfar
agent
arenavirus
b
anthraci
c
burnetii
filovirus
f
tularensi
pesti
recombinas
polymeras
amplif
rpa
altern
form
dna
amplif
techniqu
use
scan
presenc
doubl
strand
dna
templat
homolog
sequenc
rpa
rapid
highli
sensit
techniqu
detect
even
singl
copi
target
min
rpa
assay
revers
transcriptas
rpa
rtrpa
assay
success
use
detect
bwa
b
anthraci
brucella
sp
ebola
viru
f
tularensi
marburg
viru
rift
valley
fever
viru
sudan
viru
variola
viru
pesti
rtpcr
also
use
detect
chimer
virus
zika
viru
yellow
fever
viru
ebola
viru
mengla
viru
alfson
et
al
kum
et
al
yang
et
al
disadvantag
nucleic
acid
base
detect
techniqu
includ
inabl
detect
protein
toxin
jans
et
al
trombley
et
al
de
bruin
et
al
immunoassay
base
antigenantibodi
interact
wide
exploit
identif
potenti
biowarfar
agent
antibodi
bind
specif
antigen
present
surfac
cell
form
color
detect
complex
ultim
mark
presencedetect
bioagent
sampl
enzym
link
immunosorb
assay
elisa
mainli
use
quantit
detect
antigen
follow
basic
principl
immunoassay
elisa
wide
use
diagnosi
sever
diseas
simultan
screen
larg
number
sampl
thu
techniqu
highli
effici
econom
reliabl
date
elisa
success
employ
detect
biowarfar
agent
b
anthraci
b
pseudomallei
b
mallei
brucella
abortu
ebola
viru
f
tularensi
marburg
viru
toxin
pesti
besid
fluoresc
microscopi
also
use
biowarfar
agent
detect
fluoresc
label
antibodi
attach
antigen
receptor
present
surfac
microbi
cell
aid
detect
immunohistochem
base
method
also
enabl
detect
virus
alphavirus
chikanguniya
virus
wang
et
al
immunoassay
name
handheld
immunochromatograph
assay
hhia
also
use
detect
biowarfar
agent
b
anthraci
b
abortu
b
pseudomallei
botulinum
f
tularensi
smallpox
viru
ricin
toxin
variola
viru
pesti
hhia
costeffect
simpl
rapid
perform
nitrocellulos
nylon
membran
base
later
flow
immunoassay
even
sever
advantag
assay
less
sensit
specif
compar
immunolog
method
gomessolecki
et
al
wang
et
al
ghosh
goel
sharma
et
al
pal
et
al
dna
sequenc
techniqu
use
unambigu
identif
biolog
warfar
agent
nextgener
sequenc
ng
technolog
radic
chang
tradit
way
dna
sequenc
thu
open
new
vista
field
identif
bacteri
viral
biothreat
clinic
environment
sampl
ng
involv
simultan
sequenc
multipl
dna
fragment
determin
desir
sequenc
recent
year
ng
technolog
gain
much
import
valid
effect
biodefens
strategi
due
highli
specif
rapid
detect
capabl
ng
techniqu
appli
b
anthraci
detect
air
soil
sampl
strainspecif
polymorph
also
identifi
ng
case
b
anthraci
pesti
f
tularensi
detect
human
abscess
sampl
unknown
etiolog
next
gener
direct
dna
sequenc
techniqu
ng
technolog
extens
use
medic
diagnost
mainli
identif
novel
infecti
biolog
agent
diagnost
therapeut
current
unavail
cum
et
al
kuroda
et
al
lefterova
et
al
biosensor
analyt
devic
gener
respons
form
electr
signal
interact
analyt
biolog
compon
biolog
warfar
agent
biolog
respons
produc
convert
detect
form
transduc
mark
presenc
biowarfar
agent
sampl
biosensor
offer
signific
advantag
term
high
specif
select
comparison
convent
detect
techniqu
thu
wide
use
biolog
detect
biosensor
categor
differ
type
accord
type
transduc
bioreceptor
use
nanomateri
also
use
develop
highli
effici
specif
electrochem
biosensor
easi
detect
biowarfar
agent
highli
specif
electrochem
immunobiosensor
consist
bismuth
nanoparticl
binp
develop
anthrax
pa
toxin
detect
particular
sampl
anoth
electrochem
immunosensor
consist
gold
palladium
bimetal
nanoparticl
develop
detect
b
anthraci
pgml
detect
limit
b
anthraci
also
identifi
use
electrochem
genosensor
load
gold
nanoparticl
detect
pcr
amplicon
detect
limit
pm
da
et
al
botulinum
neurotoxin
type
also
identifi
electrochem
immunosensor
assembl
gold
nanoparticl
graphen
transduc
wu
cowork
report
identif
b
melitensi
use
impedometr
immunosensor
load
gold
nanoparticl
carbon
electrod
wu
et
al
surfac
plasmon
reson
spr
techniqu
also
use
labelfre
detect
variou
biolog
agent
label
free
detect
offer
signific
advantag
method
requir
secondari
label
reagent
detect
purpos
use
spr
techniqu
rapid
specif
detect
bioagent
report
b
anthraci
botulinum
neurotoxin
brucella
staphylococcu
enterotoxin
sea
b
seb
pesti
howev
piezoelectr
biosensor
use
quartz
crystal
microbal
qcm
consid
better
altern
spr
henc
also
extens
use
biolog
agent
detect
piezoelectr
immunosensor
detect
limit
cell
develop
detect
f
tularensi
immunosensor
assembl
qcm
detect
develop
detect
staphylococc
enterotoxin
milk
sampl
salmain
et
al
ghosh
et
al
gener
biolog
detector
detect
presenc
biowarfar
agent
particular
environ
without
identifi
natur
type
bioagent
howev
detector
attach
identifi
becom
capabl
identifi
natur
particular
biolog
agent
separ
independ
unit
assembl
singl
system
differ
purpos
sampl
collect
variou
type
samplerscollector
use
cyclon
sampler
viabl
particl
size
sampler
virtual
impactor
wherea
detect
identif
purpos
differ
type
detector
fluorescencebas
detector
particl
sizebas
detector
use
nowaday
biolog
detector
also
wide
use
variou
biolog
agent
detect
pal
et
al
decad
human
sole
reli
vaccin
protect
infecti
virus
howev
date
becom
complet
feasibl
develop
vaccin
viral
infect
moreov
vaccin
believ
complet
effect
infect
henderson
et
al
quinn
et
al
challeng
associ
develop
efficaci
safeti
vaccin
eventu
led
emerg
better
altern
prevent
viral
diseas
altern
effici
vaccin
directli
target
particular
viru
interrupt
life
cycl
molecular
level
use
antibodi
specif
protein
oligonucleotid
strategi
refer
biochem
prevent
treatment
consid
success
vaccin
chemic
drug
protect
human
pathogen
virus
hepat
c
viru
hcv
hiv
human
rhinoviru
hrv
biochem
prevent
treatment
strategi
gener
immedi
respons
protect
particular
infect
wherea
case
vaccin
take
longer
time
booster
dose
gener
immun
respons
strategi
work
follow
two
mechan
one
block
viral
entri
via
use
host
cell
receptor
blocker
proteinbas
specif
antivir
molecul
secondli
target
viral
mrna
inhibit
viral
replic
use
antisens
oligonucleotid
ribozym
rna
interfer
le
calvez
et
al
chimer
proteinac
toxin
prove
effect
therapeut
provid
protect
infect
two
chimer
toxin
name
fv
design
target
hiv
envelop
env
select
kill
infect
cell
chimer
toxin
test
mice
model
investig
potenti
therapeut
efficaci
hiv
markedli
suppress
acut
infect
goldstein
et
al
howev
peptidebas
drug
gener
face
issu
low
potenc
unfavor
pharmacokinet
monoclon
antibodi
mab
wide
use
biochem
therapeut
develop
chimer
human
antivir
antibodi
benefici
treatment
mani
viral
infect
fda
approv
monoclon
antibodi
known
synagi
develop
prove
success
prevent
treatment
respiratori
syncyti
viru
rsv
antibodi
inhibit
viral
replic
bind
specif
rsv
surfac
glycoprotein
consid
primari
medic
mean
provid
protect
rsv
cohen
host
cell
receptor
blocker
also
proven
effici
inhibit
viral
infect
block
viru
entri
cell
receptorblock
commonli
carri
via
applic
monoclon
antibodi
bind
specif
epitop
present
receptor
molecul
mab
gener
adhes
molecul
respons
viral
entri
attach
capabl
provid
protect
infect
caus
human
rhinovirus
hrv
marlin
et
al
howev
efficaci
mab
limit
extent
low
function
affin
adhes
molecul
comparison
multival
viral
particl
casasnova
springer
overcom
challeng
avid
function
affin
antivir
antibodi
improv
gener
recombin
antibodi
tetraval
recombin
antibodi
improv
avid
develop
capabl
prevent
hrv
infect
charl
et
al
antisenseoligonucleotid
ason
short
synthet
oligonucleotid
inhibit
viral
protein
product
block
viral
mrna
translat
also
explor
provid
protect
viral
infect
vitraven
first
ason
base
drug
potent
antivir
agent
cytomegaloviru
retin
herpeslik
eye
diseas
vitraven
bind
complementarili
viral
messeng
rna
inhibit
translat
henc
prevent
infect
caus
human
cytomegaloviru
orr
antisens
phosphorodiamid
morpholino
oligom
pmo
also
use
provid
protect
viral
infect
mainli
caus
filovirus
iversen
et
al
nan
zhang
ribozym
catalyt
activ
oligonucleotid
select
bind
cleav
target
rna
ribozym
consid
better
altern
ason
success
anim
cell
base
trial
carri
confirm
use
ribozym
potent
antivir
agent
ribozym
effici
viral
inhibitor
infect
influenza
hepat
b
c
hiv
etc
yu
et
al
tang
et
al
welch
et
al
welch
et
al
heptazym
modifi
ribozym
cleav
target
entri
site
hepat
c
viru
henc
inhibit
infect
howev
research
use
ribozym
biotherapeut
hamper
low
potenc
ineffici
vivo
intracellular
deliveri
contrast
rna
interfer
significantli
enhanc
potenc
comparison
technolog
therefor
low
level
rnai
base
antivir
drug
suffici
gener
effect
immun
respons
synthet
sirna
potenti
applic
potent
antivir
agent
rnai
technolog
success
appli
inhibit
replic
sever
pathogen
virus
filovirus
influenza
viru
polioviru
rsv
jacqu
et
al
novina
et
al
ge
et
al
ursicbedoya
et
al
ebov
marv
virus
highli
lethal
batborn
filovirus
caus
sever
hemorrhag
fever
diseas
human
sarwar
et
al
ebov
outbreak
west
africa
claim
least
live
caus
huge
econom
loss
countri
bausch
baiz
cowork
suggest
singl
spill
anim
reservoir
suffici
initi
fresh
outbreak
ebov
baiz
et
al
egyptian
fruit
bat
rousettu
aegyptiacu
identifi
like
reservoir
marv
ebov
without
develop
symptom
jone
et
al
paweska
et
al
mani
studi
report
essenti
involv
niemannpick
glycoprotein
entri
bat
human
cell
howev
magnitud
infect
may
speci
depend
filovirus
carett
et
al
et
al
hoffmann
et
al
yang
et
al
two
recent
studi
report
synthesi
chimer
virus
use
ebov
marv
leader
trailer
sequenc
discuss
fig
filoviru
call
lloviu
viru
llov
discov
first
time
spain
caus
high
mortal
negredo
et
al
recent
llov
emerg
northeast
hungari
caus
increas
mortal
miniopteru
schrei
bersii
bat
kemenesi
et
al
manhart
et
al
obtain
partial
genom
sequenc
lloviu
viru
llov
known
pathogen
show
close
rel
ebov
share
replic
strategi
llov
polymeras
also
bind
termin
nucleotid
recognit
promot
region
author
also
report
human
cell
support
replic
transcript
llov
chimer
llov
minigenom
use
ebov
marv
restv
reston
viru
leader
trailer
region
construct
studi
sequenc
event
occur
transcript
replic
infect
human
cell
thu
minigenom
strategi
prove
signific
enough
rescu
infecti
llov
clone
character
novel
minigenom
filoviru
manhart
et
al
yang
cowork
report
character
anoth
phylogenet
distinct
rel
name
viru
mlav
rousettu
bat
china
genom
sequenc
ident
known
filovirus
per
pairwis
sequenc
comparison
pasc
analysi
genom
design
mlav
new
genu
ie
dianloviru
famili
filovirida
chimer
mlav
minigenom
ebov
marv
leader
trailer
sequenc
construct
studi
replicationcompet
interspeci
spillov
transmiss
transduc
cell
line
deriv
bat
dog
hamster
human
monkey
howev
assess
risk
involv
interspeci
transmiss
need
evalu
vivo
studi
pathogenesi
mlav
yang
et
al
despit
emerg
threat
viral
epidem
potenti
util
develop
bwa
licens
vaccin
avail
chikungunya
viru
chikv
wang
et
al
darwin
et
al
kaptein
neyt
west
nile
viru
huang
et
al
chimer
virus
afford
candid
develop
vaccin
contagi
virus
shown
fig
wang
et
al
zika
viru
zikv
singlestrand
rna
flaviviru
transmit
aed
spp
mosquito
associ
variou
congenit
neurolog
complic
kb
genom
zikv
encod
singl
polyprotein
upon
action
host
viral
proteas
form
three
structur
protein
c
prm
e
seven
nonstructur
protein
ye
et
al
numer
approach
employ
develop
live
attenu
viru
et
al
inactiv
whole
viru
sumathi
et
al
subunit
dnarna
vaccin
pardi
et
al
et
al
viru
like
particl
espinosa
et
al
salvo
et
al
viru
vector
xu
et
al
chimer
zikv
kum
et
al
li
et
al
vaccin
pertain
sever
benefit
includ
econom
longterm
immun
gener
appropri
prophylact
respons
test
vivo
model
recent
work
construct
chimer
virus
potenti
vaccin
candid
zikv
vaccin
candid
base
jev
licens
live
attenu
flaviviru
vaccin
backbon
report
li
et
al
kum
et
al
prepar
chimer
viru
vaccin
construct
yfzikprm
swap
antigen
surfac
glycoprotein
prme
capsid
anchor
canch
yellow
fever
correspond
sequenc
preepidem
asian
zikv
isol
sever
tissu
cultur
adapt
mutat
also
introduc
chimer
viru
ensur
effici
replic
extracellular
viral
releas
mosquito
cell
yfzikprm
comparison
replic
inadequ
proven
avirul
mice
balbc
pup
addit
also
induc
protect
immun
respons
immunocompet
nmri
mice
model
kum
et
al
anoth
chimer
viru
compris
prme
protein
zikv
strain
integr
yellow
fever
viru
attenu
backbon
construct
touret
et
al
use
infecti
subgenom
amplicon
isa
revers
genet
method
cleavag
site
prepeptid
prm
protein
modifi
cell
studi
confer
chimer
strain
fitter
parent
one
close
relat
vaccin
strain
cell
furthermor
preimmun
mice
protect
neuroinvas
diseas
follow
challeng
heterolog
zikv
strain
research
also
report
live
attenu
vaccin
yfv
current
commerci
chin
torresi
scott
west
nile
viru
wnv
flaviviru
caus
infect
blood
sampl
vertebr
frequent
reli
plaqu
reduct
neutral
test
prnt
consid
specif
sensit
antibodi
detect
test
case
arbovirus
komar
et
al
chimer
viru
dengu
serotyp
nile
prepar
huang
et
al
coexpress
prme
wn
viru
two
vaccin
construct
name
integr
prme
specif
signal
sequenc
wn
viru
import
determin
chimer
viabil
addit
two
mutat
introduc
chimer
cdna
clone
posit
improv
viabil
featur
phenotyp
marker
attenu
vaccin
retain
chimera
report
immunogen
protect
mice
highlevel
dosag
challeng
wildtyp
wn
viru
furthermor
studi
favor
viru
carrier
develop
chimer
flaviviru
vaccin
liveattenu
chimer
vaccin
viru
wn
diseas
huang
et
al
furthermor
studi
conduct
komar
et
al
evalu
effect
chimer
construct
wnv
wildtyp
wnv
prnt
test
premembran
envelop
protein
wnv
strain
new
york
insert
gene
sequenc
attenu
strain
result
infecti
chimer
yfwn
viru
sinc
yfwn
found
attenu
wildtyp
wnv
strain
recommend
surrog
diagnost
reagent
place
wnv
prnt
assay
warn
reduc
sensit
detect
low
level
antibodi
chimer
construct
titr
neutral
antibodi
found
reduc
twofold
komar
et
al
chikv
emerg
alphaviru
first
isol
febril
human
tanzania
caus
sever
incapacit
diseas
character
fever
rash
joint
pain
persist
month
karabatso
earlier
live
attenu
highli
immunogen
chikv
vaccin
develop
use
strain
deriv
wild
type
thai
strain
levitt
et
al
howev
small
group
vaccin
human
develop
symptom
arthriti
clinic
investig
develop
vaccin
phase
ii
safeti
trial
edelman
et
al
live
attenu
vaccin
prefer
prophylact
countermeasur
involv
use
dead
organ
offer
quick
long
last
immunogen
respons
even
singl
immun
howev
high
probabl
natur
revers
dissemin
reactogen
virul
charact
load
develop
viral
diseas
viremia
contrast
chimer
vaccin
light
chanc
produc
viremia
test
anim
model
wang
et
al
thu
chimer
alphaviruschikv
vaccin
candid
construct
use
three
recombin
alphavirus
backbon
ie
sindbi
viru
sinv
vaccin
strain
venezuelan
equin
enceph
viru
veev
eastern
equin
enceph
viru
eeev
strain
express
chikv
structur
protein
gene
chimera
replic
effici
highli
attenu
mice
model
produc
robust
neutral
antibodi
respons
interestingli
eeev
backbon
present
ed
greater
immunogen
vaccin
mice
fulli
protect
diseas
chikv
challeng
wang
et
al
later
wang
et
al
provid
convincingli
evid
support
product
appropri
immun
respons
develop
chimer
virus
immunocompet
immunocompromis
mice
wang
et
al
chimer
vaccin
candid
name
eeechikv
prepar
use
structur
gene
chikv
nonstructur
protein
gene
veev
vaccin
strain
eeev
potenti
two
construct
infect
chikv
vector
aed
aegypti
ae
albopictu
assess
comparison
parent
wild
strain
found
poorli
infecti
lower
dissemin
rate
might
mediat
midgut
infect
barrier
henc
eeechikv
adequ
attenu
mosquito
infect
affirm
develop
human
vaccin
prevent
chikv
darwin
et
al
enteroviru
caus
hand
foot
mouth
diseas
bovin
anim
human
compris
subgenotyp
henc
vaccin
desir
protect
opposit
subgenotyp
ye
team
report
construct
two
chimera
prepar
fusion
hepat
b
core
antigen
hbc
epitop
respect
studi
potenti
mechan
action
chimera
prepar
selfassembl
viru
like
particl
vlp
due
presenc
epitop
display
surfac
carrierand
epitopespecif
antibodi
respons
induc
upon
immun
chimer
construct
mice
model
lethal
infect
interestingli
comparison
serum
abl
hinder
attach
vulner
cell
wherea
vitro
postattach
stage
sera
counteract
infect
henc
chimera
exhibit
epitop
prove
promis
candid
broadspectrum
vaccin
ye
et
al
chimera
virus
also
exploit
treatment
diseas
human
herp
viru
infect
induc
cancer
infect
mice
model
chimera
viru
develop
mous
viru
human
viral
gene
inhibit
human
lana
protein
essenti
maintain
infect
caus
cancer
treatment
human
herp
viru
infect
associ
cancer
strategi
also
appli
gener
chimera
virus
effect
lethal
virus
epsteinbarr
viru
human
papilloma
viru
respons
cervic
cancer
habison
et
al
recent
chimer
antigen
receptor
cart
cell
develop
treatment
relaps
refractori
acut
lymphoblast
leukemia
cart
cell
specif
target
kill
tumor
cell
express
tumor
antigen
cart
cell
therapi
also
employ
protect
hematolog
malign
ovarian
cancer
pancreat
cancer
prostat
cancer
jhaveri
rosner
effect
decontamin
system
requir
combat
threat
bioterror
attack
minim
advers
effect
caus
hazard
biolog
agent
tradit
method
decontamin
biowarfar
agent
involv
use
bleach
decontamin
solut
gener
refer
wet
solut
spread
infecti
agent
limit
particular
environ
space
easili
transmit
form
one
place
anoth
mean
spore
henc
necessari
decontamin
concern
surfac
build
also
local
smallscal
remedi
usual
done
treat
contamin
surfac
liquid
formul
decontamin
solut
hydrogen
peroxid
chlorin
dioxid
ga
dissolv
water
phenol
sodium
hypochlorit
quaternari
ammonium
compound
decontamin
foam
largescal
remedi
done
fumig
chlorin
dioxid
ga
specif
locat
test
decontamin
agent
includ
ethylen
oxid
glutaraldehyd
hydrogen
peroxid
vapor
peracet
acid
orthophthalaldehyd
ozon
paraformaldehyd
chemic
decontamin
known
potenti
effect
b
anthraci
spore
chlorin
dioxid
ga
consid
one
best
decontamin
altern
fumig
heavili
contamin
infect
area
howev
timeconsum
take
long
contact
time
chemic
solut
disinfect
virus
spore
remov
fresh
water
wash
soap
water
also
gener
person
decontamin
procedur
wash
hot
soapi
water
remov
biolog
contamin
emerg
respond
expos
biolog
agent
alcohol
solut
also
consid
effect
decontamin
hard
nonpor
surfac
gener
alcohol
solut
use
decontamin
biolog
contamin
highli
flammabl
use
alcohol
solut
restrict
particular
level
autoclav
dri
heat
thermal
washer
disinfect
ultrason
steril
commonli
use
decontamin
procedur
method
effect
biolog
agent
dispos
decontamin
reagent
contamin
wast
water
still
challeng
henc
use
peril
chemic
limit
extent
requir
special
biosafeti
approv
storag
transport
dispos
also
risk
associ
use
wet
chemic
often
lead
corros
materi
leather
plastic
paint
metal
rubber
skin
use
hazard
chemic
sensit
equip
materi
recommend
moreov
chemic
nonspecif
natur
releas
environ
lead
toxif
degrad
natur
resourc
thu
exist
decontamin
system
thoroughli
effect
hawley
eitzen
raber
et
al
kumar
et
al
strong
need
ideal
ecofriendli
decontamin
technolog
focu
select
effect
disinfect
biowarfar
agent
decontamin
requir
gener
present
dri
form
easili
transport
mass
storag
requir
fast
work
henc
altern
decontamin
method
develop
includ
use
ioniz
nonion
radiat
thermal
energi
reactiv
gase
produc
plasma
ioniz
gamma
radiat
also
use
decontamin
biolog
agent
somehow
led
destruct
sensit
equip
nonion
ultraviolet
uv
radiat
also
test
destruct
biolog
agent
success
techniqu
limit
resist
dri
spore
uv
radiat
thermal
energi
method
also
tri
effici
limit
temperatur
constraint
also
lead
damag
surfac
equip
method
rel
time
consum
portabl
arcseed
microwav
plasma
torch
develop
appli
decontamin
biolog
warfar
agent
emiss
spectroscopi
plasma
torch
reveal
product
ampl
amount
reactiv
atom
oxygen
effect
oxid
biolog
agent
moreov
plasma
ga
highli
energ
state
highli
reactiv
capabl
destruct
kind
organ
contamin
mean
nontherm
method
decontamin
purpos
b
cereu
select
simul
b
anthraci
spore
result
reveal
spore
kill
cm
distanc
cm
distanc
cm
distanc
away
nozzl
torch
thu
plasma
torch
also
use
altern
decontamin
techniqu
lai
et
al
research
develop
project
also
initi
provid
novel
decontamin
system
biowarfar
agent
key
focu
effect
econom
fast
nontox
specif
decontamin
project
also
aim
develop
adsorpt
elimin
technolog
deactiv
technolog
use
photocatalysi
techniqu
seto
vacuum
clean
hepa
filtrat
also
consid
effect
decontamin
method
reduc
particul
load
allow
effect
remedi
hepa
vacuum
report
effici
fumig
procedur
present
scenario
exist
decontamin
system
effect
specif
thu
effici
limit
extent
thu
author
propos
strong
need
develop
effect
specif
ecofriendli
decontamin
technolog
key
focu
select
effect
disinfect
biowarfar
agent
raber
et
al
fitch
et
al
wei
et
al
biolog
warfar
use
impun
camouflag
natur
outbreak
diseas
decim
human
popul
destroy
livestock
crop
econom
signific
rapid
evolut
synthet
biolog
techniqu
construct
synthet
biolog
agent
use
next
gener
bioweapon
rapidli
increas
eventu
enhanc
risk
biolog
warfar
compar
past
mani
draft
whole
genom
sequenc
import
pathogen
bacteria
virus
infect
human
decod
date
access
nucleic
acid
sequenc
databas
genbank
embl
ddbj
gdb
human
genom
db
microbi
genom
db
compar
analysi
mbgd
virul
factor
bacteri
pathogen
vfdb
nation
microbi
pathogen
db
resourc
nmpdr
viru
pathogen
resourc
vipr
integr
db
viral
genom
virusit
barcod
life
data
system
ctd
compar
toxicogenom
db
etc
exist
virtual
platform
form
essenti
gene
virul
factor
synthet
construct
human
infecti
element
provid
huge
scope
bioweapon
develop
next
gener
bioweapon
base
design
gene
design
diseas
model
instig
seriou
consequ
futur
bioterror
attack
simpl
alter
genet
compliment
may
make
pathogen
deadli
exist
natur
form
emerg
next
gener
bioweapon
includ
chimer
agent
previous
unknown
man
even
danger
challeng
natur
agent
cross
barrier
pathogen
also
due
current
limit
method
detect
protect
decontamin
exist
huge
knowledg
gap
need
attent
develop
appropri
defens
strategi
biowarfar
agent
histor
evid
clearli
predict
asymmetr
correl
offens
defens
biowarfar
strategi
discontinu
biowarfar
program
seriou
limit
nation
abil
develop
appropri
defens
tool
antibiot
vaccin
therapeut
deploy
biowarfar
program
militari
doctrin
nation
without
endang
militari
allianc
alway
advantag
nation
secur
protect
vulner
civilian
popul
addit
domest
law
use
bioweapon
enact
biolog
toxin
weapon
convent
strengthen
legal
bind
instrument
author
highli
recommend
use
physic
protect
prophylact
measur
elimin
natur
spread
exist
contagi
biowarfar
agent
mass
scale
especi
among
vulner
popul
children
poor
immun
arm
forc
involv
direct
combat
war
front
